12104 Federal Register / Vol. 78, No. 35 / Thursday, February 21, 2013 / Notices 

Drug Schedule 

Amobarbital (2125) ......................... II 

Pentobarbital (2270) ....................... II 

Secobarbital (2315) ........................ II 

4-Anilino-N-phenethyl-4-piperidine 

(ANPP) (8333).

II 

Phenylacetone (8501) .................... II 

Cocaine (9041) ............................... II 

Codeine (9050) .............................. II 

Dihydrocodeine (9120) ................... II 

Oxycodone (9143) .......................... II 

Hydromorphone (9150) .................. II 

Diphenoxylate (9170) ..................... II 

Ecgonine (9180) ............................. II 

Hydrocodone (9193) ...................... II 

Meperidine (9230) .......................... II 

Methadone (9250) .......................... II 

Morphine (9300) ............................. II 

Thebaine (9333) ............................. II 

Oxymorphone (9652) ..................... II 

Alfentanil (9737) ............................. II 

Remifentanil (9739) ........................ II 

Sufentanil (9740) ............................ II 

Fentanyl (9801) .............................. II 

The company plans on manufacturing 

the listed controlled substances in bulk 

for sale to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a), and 

determined that the registration of Cody 

Laboratories, Inc., to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Cody Laboratories, Inc., to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed. 

Dated: February 8, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–03881 Filed 2–20–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

Cedarburg Pharmaceuticals, Inc. 

By Notice dated November 5, 2012, 

and published in the Federal Register 

on November 13, 2012, 77 FR 67676, 

Cedarburg Pharmaceuticals, Inc., 870 

Badger Circle, Grafton, Wisconsin 

53024, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Drug Schedule 

4-Anilino-N-phenethyl-4-piperidine 

ANPP) (8333).

II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Regarding the drug code (8333), the 

company plans to use this controlled 

substance to manufacture another 

controlled substance. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a), and 

determined that the registration of 

Cedarburg Pharmaceuticals, Inc., to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Cedarburg Pharmaceuticals, 

Inc., to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed. 

Dated: February 8, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–03885 Filed 2–20–13; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration; 

INB Hauser Pharmaceutical Services, 

Inc. 

By Notice dated November 1, 2012, 

and published in the Federal Register 

on November 9, 2012, 77 FR 67398, InB 

Hauser Pharmaceutical Services, Inc., 

6880 N. Broadway, Suite H, Denver, 

Colorado 80221, made application by 

letter to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of 4-Anilino-Nphenethyl-4-piperidine (8333), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to manufacture 

the listed controlled substance in bulk 

for distribution and sale to its 

customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a), and 

determined that the registration of InB 

Hauser Pharmaceutical Services, Inc., to 

manufacture the listed basic class of 

controlled substance is consistent with 

the public interest at this time. DEA has 

investigated InB Hauser Pharmaceutical 

Services, Inc., to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems; verification of the 

company’s compliance with state and 

local laws; and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above named company is 

granted registration as a bulk 

manufacturer of the basic class of 

controlled substance listed. 

Dated: February 8, 2013. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2013–03886 Filed 2–20–13; 8:45 am] 

BILLING CODE 4410–09–P 

NATIONAL FOUNDATION ON THE 

ARTS AND THE HUMANITIES 

Proposed Collection of Information; 

Comment Request 

AGENCY: National Endowment for the 

Arts, National Foundation on the Arts 

and the Humanities. 

ACTION: Notice. Proposed collection; 

comment request. 

SUMMARY: The National Endowment for 

the Arts (NEA), as part of its continuing 

effort to reduce paperwork and 

respondent burden, conducts a 

preclearance consultation program to 

provide the general public and federal 

agencies with an opportunity to 

comment on proposed and/or 

continuing collections of information in 

accordance with the Paperwork 

Reduction Act of 1995 (PRA95) [44 

U.S.C. 3506(c)(A)]. This program helps 

to ensure that requested data can be 

provided in the desired format, 

reporting burden (time and financial 


erowe on DSK2VPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 35 / Thursday, February 21, 2013 / Notices 12105 

resources) is minimized, collection 

instruments are clearly understood, and 

the impact of collection requirements on 

respondents can be properly assessed. 

Currently, the NEA is soliciting 

comments concerning conducting new 

information collection on arts activities 

that involve live audiences and that are 

funded through its Art Works program. 

A copy of the survey instrument to be 

used in the information collection can 

be obtained by contacting the office 

listed below in the address section of 

this notice. 

DATES: Written comments must be 

submitted to the office listed in the 

address section below on or before April 

16, 2012. The NEA is particularly 

interested in comments which: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

ADDRESSES: Sunil Iyengar, National 

Endowment for the Arts, 1100 

Pennsylvania Avenue, NW., Room 616, 

Washington, DC 20506–0001, telephone 

(202) 682–5424 (this is not a toll-free 

number), fax (202) 682–5677. 

Dated: February 15, 2013. 

Kathy Plowitz-Worden, 

Panel Coordinator, National Endowment for 

the Arts. 

[FR Doc. 2013–03937 Filed 2–20–13; 8:45 am] 

BILLING CODE 7537–01–P 

NATIONAL FOUNDATION FOR THE 

ARTS AND THE HUMANITIES 

Submission for OMB Review, 

Comment Request, Proposed 

Collection: Public Needs for Library 

and Museum Services (PNLMS) Survey 

AGENCY: Institute of Museum and 

Library Services. 

ACTION: Submission for OMB Review, 

Comment Request. 

SUMMARY: The Institute of Museum and 

Library Services (IMLS), as part of its 

continuing effort to reduce paperwork 

and respondent burden, conducts a preclearance consultation program to 

provide the general public and federal 

agencies with an opportunity to 

comment on proposed and/or 

continuing collections of information in 

accordance with the Paperwork 

Reduction Act (44 U.S.C. Chapter 35). 

This pre-clearance consultation program 

helps to ensure that requested data can 

be provided in the desired format, 

reporting burden (time and financial 

resources) is minimized, collection 

instruments are clearly understood, and 

the impact of collection requirements on 

respondents can be properly assessed. 

A copy of the proposed information 

collection request can be obtained by 

contacting the individual listed below 

in the ADDRESSES section of this notice. 

DATES: Written comments must be 

submitted to the office listed in the 

addressee section below on or before 

March 20, 2013. 

IMLS is particularly interested in 

comments that help the agency to: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated electronic, 

mechanical, or other technological 

collection techniques, or other forms of 

information technology, e.g., permitting 

electronic submissions of responses. 

ADDRESSES: Deanne Swan, Senior 

Statistician, Office of Planning, 

Research, and Evaluation, Institute of 

Museum and Library Services, 1800 M 

St. NW., 9th Floor, Washington, DC 

20036. Dr. Swan can be reached by 

Telephone: 202–653–4769, Fax: 202– 

653–4601, or by email at 

dswan@imls.gov, or by teletype (TTY/ 

TDD) for persons with hearing difficulty 

at 202–653–4614. 

SUPPLEMENTARY INFORMATION: The 

Institute of Museum and Library 

Services is the primary source of federal 

support for the Nation’s 123,000 

libraries and 17,500 museums. The 

Institute’s mission is to create strong 

libraries and museums that connect 

people to information and ideas. The 

Institute works at the national level and 

in coordination with state and local 

organizations to sustain heritage, 

culture, and knowledge; enhance 

learning and innovation; and support 

professional development. IMLS is 

responsible for identifying national 

needs for, and trends of, museum and 

library services funded by IMLS; 

reporting on the impact and 

effectiveness of programs conducted 

with funds made available by IMLS in 

addressing such needs; and identifying, 

and disseminating information on, the 

best practices of such programs. (20 

U.S.C. Chapter 72, 20 U.S.C. 9108). 

Abstract: Consistent with this (20 

U.S.C. Chapter 72, 20 U.S.C. 9108), the 

intention of the PNLMS (formerly the 

PDMLS, Public Demand for Museum 

and Library Services Survey) is to 

monitor expectations of and satisfaction 

with library and museum services. A 

wide range of topics will be covered, 

with a small number of questions about 

each topic included on the 

questionnaire. The PNLMS will include 

a core set of demographic questions 

(e.g., age, gender, race) and a core set of 

questions based on critical information 

needs within IMLS (e.g., satisfaction 

with the library and museum services; 

frequency of utilization of various 

services; physical and virtual access to 

services). 

The purpose of this collection is to 

determine attitudes, to assess awareness 

of issues related to library and museum 

services, and to track trends. The survey 

will be used to gather information on a 

wide range of library and museum 

services. The design of the PNLMS will 

be a random digital dial (‘‘RDD’’) 

telephone survey of the adult, noninstitutionalized U.S. population which 

will yield a minimum of 3,525 cases. 

Current Actions: This notice proposes 

clearance of the Public Needs for 

Library and Museum Services (PNLMS) 

Survey. The 60-day notice for the 

PDMLS (now PNLMS) Survey was 

published in the Federal Register on 

November 29, 2010, (FR vol. 75, No. 

228, pgs. 73132–73133). The agency has 

taken into consideration the comment 

that was received under this notice. 

Agency: Institute of Museum and 

Library Services. 

Title: Public Needs for Library and 

Museum Services Survey. 

OMB Number: To Be Determined. 

Agency Number: 3137. 

Affected Public: Individuals or 

households. 

Number of Respondents: 3,525. 

Frequency: Anticipated for Every 

Three Years. 


erowe on DSK2VPTVN1PROD with NOTICES